Background {#Sec1}
==========

Chromosome instability syndromes are a group of inherited conditions associated with chromosomal instability and breakage which includes LIG4 \[[@CR1],[@CR2]\], Seckel type 1 \[[@CR3],[@CR4]\], Bloom syndrome \[[@CR5]\], Nijmegen breakage syndrome \[[@CR6]-[@CR8]\], and Fanconi anemia. These genetic conditions are characterized by pre and postnatal growth retardation, microcephaly, dysmorphic features and bone marrow failure \[[@CR9]-[@CR11]\]. There are other conditions with overlapping phenotypes including microcephaly, such as Rad50 deficiency \[[@CR12],[@CR13]\], Cernunnos-XLF syndrome \[[@CR14]\] and Warsaw breakage syndrome \[[@CR15]-[@CR18]\] which can complicate molecular diagnosis. FILS syndrome (facial dysmorphism, immunodeficiency, livedo, and short stature) is a recently described condition caused by variants in *POLE1*, encoding the catalytic subunit of polymerase E. We describe the second family with a homozygous variant in *POLE1,* and a more severely affected individual, suggesting a broader phenotypic spectrum for this condition.

Case presentation {#Sec2}
=================

Patient CMH812 is a female infant born to healthy non consanguineous Palestinian parents, weighing 1745 g and measuring 38.1 cm at birth. The pregnancy was complicated by subchorionic bleeding in the first trimester, fetal abnormalities on ultrasound including intrauterine growth restriction, short long bones, suspected skull abnormalities and oligohydramnios. TORCH titers were negative. Amniocentesis revealed normal 46,XX karyotype. She was delivered at 37 weeks gestation by elective C-section secondary to breech presentation. Dysmorphic features noted included malar and mandibular hypoplasia (Figure [1](#Fig1){ref-type="fig"}A, B). Initial clinical suspicion was for primordial dwarfism such as Seckel type 1 syndrome, however her microcephaly was not as severe. Over several months, lacy reticular pigmentation was noted of the face and extremities. She had recurrent pruritic papular eruptions and skin findings progressed to include appearance of poikiloderma (Figure [1](#Fig1){ref-type="fig"}C, D). Erupted teeth were found to be small and dysplastic. She developed a feeding aversion necessitating a gastrostomy tube. Growth remained poor postnatally (Figure [2](#Fig2){ref-type="fig"}). Her motor milestones were delayed but social development was normal.Figure 1Clinical characteristics of CMH812. Several congenital abnormalities were found, including **(A)** microcephaly, facial dysmorphism (small and bird-like face, malar and mandibular hypoplasia, prominent nasal bridge and columella, downslanting palpebral fissures, small mouth and low set, posteriorly rotated ears) **(B)** short stature with shortened long bones but no evidence of dysplasia or craniosynostosis. No major anomalies were found on imaging of her abdomen, brain, brain vasculature or heart. Genitalia and pubertal development were normal. No malabsorption or pituitary or thyroid insufficiency was found. **(C-D)** Skin findings in CMH812, showing one hypo- and three hyperpigmented patches on the skin. Biopsy of the skin was performed but not diagnostic. Microscopic examination displayed focal parakeratosis and mild spongiosis.Figure 2Growth charts of CMH812. The patient is a female with severe intrauterine and postnatal growth retardation head circumference **(A)** \[\<3rd centile\]; weight **(B)** \[\<2nd centile\], length **(C)** \[\<2nd centile\], based on CDC growth chart for girls, age 0--20 months. Growth remained poor postnatally and she was briefly started on growth hormone, which was discontinued due to suspicion for a disorder of DNA repair/instability. At age 15 months she was \~5 SD below the mean for weight and length and \~3-4 SD below the mean for head circumference.

She suffered chronic rhinosinusitis and pulmonary infections with purulent otitis media. At age 20 months she was admitted to the hospital with pancytopenia, splenomegaly, hepatitis and acute CMV infection. Laboratory data showed mild bone marrow myelodysplasia, normal total B, T, and NK cells, low class switched and non switched memory B cells, and high memory T cells. She had high IgA, normal total IgG and low IgM, IgG2 and IgG4. There was no serologic response to pneumococcal vaccine (Table [1](#Tab1){ref-type="table"}). Lymphocyte response to mitogens was normal but absent to pertussis and candida antigens \[[@CR11]\]. Hepatitis and pancytopenia resolved following the CMV infection. Extensive molecular and cytogenetic testing was negative, including array-CGH, telomere length studies, chromosome breakage, and gene sequencing with deletion/duplication analysis for the following genes: *ATM, ATR, BLM, CENPJ, CEP152, CEP63, ERCC6, ERCC8, LIG4, LMNA, MRE11A, NBN, PCNT, RBBP8, RECQL4, SHOX, WRN,* and *ZMPSTE24.*Table 1**Comparison of clinical features of** ***POLE1*** **patients and other chromosome instability syndromesClinical featuresTAR syndromeAtaxia telangiectasiaRAD50 deficiencyFanconi anemiaSeckel syndromeNBSRS/SC syndromeWarsaw syndromeCernnos-XLF syndromeBloom syndromeLIG4 syndrome2FILS syndrome\*CMH812**MIM **\#**274000208900613078227650210600251260268300 /269000613398611291210900606593615139615139Microcephaly−ννννννννννννMalar hypoplasia−n.aν−n.an.aνν−νn.aννSloping headν−n.a−ννννν−νννPalpebral fissures, upslanting−−n.a−−ν−ν−−νν−Palpebral fissures, down-slanting−−ν−ν−ννν−−ννEpicanthic folds−−ν−−νννν−νννMicrognathiaν−n.a−ννννν−−ν−External ear abnormalities−−n.aννννννν−ννLong/Large noseν−ν−−ννννννν−Long philtrum−−n.a−−νννν−−ννCleft palate/high arched palate−−n.a−νννν−−−−−Polydactily−−n.aν−ν−−−ν−−−Clinodactily−−n.a−νννν−νν−νSyndactilyGrowth retardation−ννννννννννννShort statureννn.aννννννννννBone disease or anomaliesν−n.aνν−νn.aν−−ννThumb apasia/radial ray anormalitiesν−n.aνν−−/νn.a−−ν−Skin abnormalitiesνννννννννννννMental retardationννννννννν−ν−−Developemental delayννννννννννν−νMalignancyνν−ννννn.aννν−−Recurrent infections−ν−ννννννννννGenital abnormalities−−−ννννn.a**−**−ν−−Ataxia−νν−νn.a**−**n.a**−**n.an.a−−Brain anomalie/degenerationCA, CH, aCC, SCA, CH,T, SNDνCA, CH, PG, SNDSn.aPGn.an.an.a−Endocrine−AZ, D, DP, HH−HHD, DPPOFn.an.a−AZ, D RF−−−Immunologic FeaturesPancytopenia−n.an.aνν−n.an.aν−ν−νThrombocytopeniaνn.a−ν−−n.an.a−−−−νCID−ν−−n.a−n.an.aνn.aν2/14νSCID−ν−−ν−n.an.aνn.aνn.a-Neutropenia−n.an.aνn.aνn.an.aνNνn.a-\*B cell lymphocytopenia−νNν−−n.an.aν−2/17ννT cell lymphocytopenia−νNνννn.an.aννNννIgAn.a↓NN↓n.an.an.a↓↓↓N↑IgEn.a↓Nn.a↓n.an.an.an.aNn.aNNIgGn.a↓N↓↓n.an.an.a↓↓n.a↓↓\*\*IgMn.a↓N↓↓n.an.an.a↓↓↓↓↓Anti-pseudomonaen.an.aNn.a↓n.an.an.aνn.an.aννpolysaccaride IgGAuto-immunityn.aν−n.a↓νn.an.a1/17n.a0/17−-Sister chromatiden.a−n.an.a↑ or Nνννn.aνn.aNNDNA breakage studiesn.aνννννννννn.a−NRadiosensitivityn.aνννννννννν−n.a.GeneRBM8AATMRAD50FANCATRNBS1ESCO2DDX11NHEJ1BLMLIG4POLE1POLE1Mode of InheritanceARARARARARARARARARARARARARLegendn.a; not reported/applicable.−; negative.ν; positive.N; normal range.↓; decreased.↑; increased.NBS: Nijmegen breakage syndrome.TAR: Thrombocytopenia-absent radius syndrome.RS: Roberts syndrome.SC: SC phocomelia syndrome.aCC; absence of corpus collosum.AR; autosomal recessive.AZ; azoospermia.CA; cerebellar ataxia.CH; cerebellar hypoplasia.CID; combined immunodeficiency.D; diabetes.DP; delayed puberty.HH; hypergonadotropic hypogonadism.NBS; Nijmegen breakage syndrome.ND; neurodegenerative.OA; oculomotor apraxia.PG; polygyria.POF; primary ovarian failure.RF; reduced fertility.S; seizures.SCID; severe combined immunodeficiency.T; Tremor.\*consanguineous family reported.£ Ataxia-telangiectasia-like disorder.- \* Transient pancytopenia associated with CMV infection.↓\*\* IgG2 and IgG 4 ↓. Total IgG N.

Trio-exome sequencing was performed on CMH812 and her healthy parents (CMH813 & CMH814) following informed consent, and with methods as previously published \[[@CR19]-[@CR22]\]. Variants were filtered to 1% minor allele frequency, then prioritized by the American College of Medical Genetics (ACMG) categorization \[[@CR23],[@CR24]\], OMIM identity and phenotypic assessment. This individual was homozygous for a splice-site variant, c.4444 + 3A \> G, in intron 34 of the *POLE*1 \[[@CR11]\]. The parents were both heterozygous carriers (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Homozygosity mapper was used to identify intervals of homozygosity and identity by descent segments (Additional file [2](#MOESM2){ref-type="media"}: Figure S1) \[[@CR25]\].

The c.4444 + 3A \> G variant was previously reported in consanguineous French family with three generations of affected members \[[@CR11]\]. FILS phenotype was variable but included macrocephaly, recurrent respiratory infections, livedo and telangiectasia, bone dysplasia, short stature, and decreased IgM and IgG. The phenotype was considered similar to that of Bloom syndrome but with normal sister chromatid exchange. Table [1](#Tab1){ref-type="table"} compares the clinical and cellular features of CMH812 to those of individuals with inherited chromosomal instability and breakage syndromes, as well as the first reported FILS family. Features closely matched those reported in FILS with exceptions of microcephaly and intrauterine growth restriction. Although the *POLE1* variant identified in the present case is the same as previously reported, CMH812 seems to have had more significantly impaired growth and immunity, raising the hypothesis that rare variant(s) in other POLƐ subunits or MMR genes may act as phenotypic modifiers. However, no rare variant were detected in MMR genes, POLE1 interacting proteins or other DNA breakage/instability syndrome genes.

The c.4444 + 3A \> G *POLE*1 variant confers abnormal splicing whereby exon 34 is deleted \[[@CR11]\] leading to significant decrease in the POLE1 subunit \[[@CR11]\]. T- lymphocytes from affected individuals showed a proliferation defect as well as impaired cell cycle progression. The primary function of polymerase Ɛ1 is to synthesize DNA at the leading strand during replication \[[@CR26],[@CR27]\], however, it is also involved in other cellular processes, including cell cycle progression and DNA repair/recombination \[[@CR26],[@CR27]\]. Exonucleolytic proofreading and the MMR pathway act to maintain high-fidelity DNA replication and to protect against mutagenesis \[[@CR28]\]. Somatic and germline heterozygous missense variants in POLƐ1 have been associated with an increased cancer risk \[[@CR28]-[@CR32]\]. Functional studies in yeast showed that heterozygosity for a pathogenic allele can cause complete MMR deficiency, and that subsequent loss of heterozygosity is not required for the development of POLE-related tumors \[[@CR28]\]. Taken together, these findings suggest that *POLE1* carriers are likely to be at increased risk for malignancy due to MMR deficiency.

Conclusions {#Sec3}
===========

In summary, we report a second family with *POLE1*-related disease. The clinical and immunologic features of our patient are reminiscent of LIG4 syndrome, possibly representing the more severe end of an ill-defined clinical spectrum. For this reason, POLE1 deficiency may be a more apt description of this disorder. This report illustrates the cost-effectiveness of trio-exome sequencing as a powerful diagnostic method considering that this family underwent an extensive diagnostic odyssey, with no molecular basis identified prior exome.

Consent statement {#Sec4}
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The project was approved by the research ethics committee of the Children's Mercy Hospitals. Written informed consent was obtained from the patient's legal guardians for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
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Additonal file 1: Table S1.Trio-Exome sequencing data.Additonal file 2: Figure S1.Homozygosity Mapping Analysis. Homozygosity mapper was used to identify intervals of homozygosity. The homozygosity scores are plotted against the physical position. Red and black bars represent the excess (red) or the shortage (black) of homozygosity **(A)** Eighteen loci of \> 1 Mb of homozygosity were identified on seven chromosomes; loci ranged between 1.06 and 6.37 Mb in length. The length of identical by descent segments in genomes of CMH812 parents suggests that they are not closely related. However, they shared several relatively small identical segments of genome which is explained by the shared ancestry broken into pieces by the recombination events and Mendelian laws of inheritance. *POLE1* lies in a 1.1 Mb region of homozygosity on chromosome 12 (chr12:132635257--133702440), which includes 20 genes **(B)**. It is reasonable to hypothesize that the *POLE1* variant, if not the result of a combination of recent origin and chance, owes its origin to a founder who lived several hundred years ago. Consistent with the rarity of the c.4444 + 3A \> G variant and the small physical distances between each haplotype marker in relationship to *POLE1* gene (1.1 Mb); the size of the shared haplotype may have been broken into smaller segments due to genetic drift. This assumption could explain that the same variant (c.4444 + 3A \> G) has been found in two apparently unrelated FILS families.
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